Indian
Niti studying proposal to tax foods high in sugar, salt to tackle obesity
''Niti Aayog, in collaboration with IEG and PHFI, is reviewing the...
Russia-Ukraine war: ECGC withdraws coverage for shipments to Russia
Amid the ongoing conflict between Russia and Ukraine, ECGC in a...
Government allows up to 20 per cent FDI in LIC under automatic route
Under current rules, foreign investment is not allowed in the LIC,...
Tata in talks with aircraft makers over order for Air India: Sources
Tata had begun preliminary discussions with the planemakers and...
International
Victory for UK firms in court battle over COVID-19 BI insurance claims
UK High Court rules in policyholders’ favour in landmark business insurance case
Some 370,000 firms which lost earnings as a result of lockdown could expect up to £1.2billion in damages
However, insurers are expected to appeal the decision – meaning firms will likely have to wait months before seeing any payout
Pandemic’s ‘great reset’ makes energy firms invest more in renewables: executives
Reeling from the onset of the pandemic, global oil consumption shrank by more than 20% in the second quarter and prices hit their lowest in decades, making companies rethink how fast they should make the transition away from reliance on oil and gas.
“Everyone’s talking about this great reset . What do we need to do to survive this?” Arif Mahmood, Petronas’ executive vice president and CEO of downstream, said at the virtual Platts APPEC 2020.
“Energy transition will be pushed forward much faster,” he concluded.
China’s Anbang Insurance Group to apply to disband, liquidate
After the Anbang take-over, China has tightened regulations on the country’s financial holdings companies to defuse risks accumulated by a group of non-financial firms that it says expanded blindly into the financial sector.
On Sunday, the People’s Bank of China (PBOC) issued related new rules, setting requirements on registered capital, total assets, and assets under management on eligible financial holdings firms.
Novavax aims for 2 billion COVID-19 vaccine doses with expanded India deal
Novavax’s vaccine is currently in mid-stage trials after an early-stage study showed it produced high levels of antibodies against the novel coronavirus. The company plans to begin late-stage trials in the third quarter.Last month, Novavax said it will supply 60 million doses of its coronavirus vaccine candidate to the UK beginning as early as the first quarter of 2021.
Briefs
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Events
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Articles
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Features
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Data
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Interviews
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Facts
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
